版本:
中国

BRIEF-Cumberland Pharmaceuticals reports q1 adjusted EPS $0.02

May 15 Cumberland Pharmaceuticals Inc

* Cumberland pharmaceuticals reports revenue growth of 25% in first quarter 2017

* Q1 revenue $9.6 million versus $7.7 million

* Q1 adjusted earnings per share $0.02

* Says for three months ended march 31, 2017, net revenues were $9.6 million, compared to $7.7 million

* Qtrly loss per share attributable to common shareholders $0.08 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐